Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZT-01 Pharmacodynamics in T1D
NCT05007977Phase 1Terminated
- Sponsor
- Zucara Therapeutics Inc.
- Start
- Jul 2021
- Primary completion
- Apr 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ZT-01 in hypoglycemia (6 arms), sponsored by Zucara Therapeutics Inc. Primary endpoint: Change in glucagon between euglycemia and hypoglycemia. Started Jul 2021; status: terminated.
02
Drugs
ZT-01
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT05007977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05007977.